OnKure Therapeutics, Inc

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie, Gilgamesh To Investigate Potent

It may not be as easy for private biopharmaceutical companies to raise a new venture capital round in 2023 as it was during the past few years, but VC firms have brought in an impressive amount out ca

Cash is flooding into biopharmaceuticals, but regenerative medicine companies in particular have raked in large sums of cash – in part, because of the high upfront investment in manufacturing, but als